Relation of Serum Total Cholesterol, C-Reactive Protein Levels, and Statin Therapy to Survival in Heart Failure

American Journal of Cardiology

Volumn 98, Issue 5, 2006, Pages 653-658

  May, Heidi T ^a   Muhlestein, Joseph B ^a,b   Carlquist, John F ^a,b   Horne, Benjamin D ^a   Bair, Tami L ^a   Campbell, Beverly A ^a   Kfoury, Abdallah G ^a,b   Lyon, Joseph L ^b   Kim, Han ^b   Renlund, Dale G ^a,b  

^a LDS HOSPITAL   (United States)

^b UNIVERSITY OF UTAH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DEATH; DISEASE ASSOCIATION; FEMALE; HEART EJECTION FRACTION; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN BLOOD LEVEL; SURVIVAL;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHOLESTEROL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 33747176022     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.03.046     Document Type: Article

References (23)

1. Windler E., Wers-Grabow U., Thiery J., Walli A., Seidel D., and Greten H. The prognostic value of hypocholesterolemia in hospitalized patients. Clin Invest 72 (1994) 939-943
2. Pinilla J.C., Hayes P., Laverty W., Arnold C., and Laxdal V. The C-reactive protein to prealbumin ratio correlates with the severity of multiple organ dysfunction. Surgery 124 (1998) 799-805
3. Waydhas C., Nas-Kolb D., Trupka A., Zettl R., Kick M., Wiesholler J., Schweiberer L., and Jochum M. Posttraumatic inflammatory response, secondary operations, and late multiple organ failure. J Trauma 40 (1996) 634-640
4. Ikei S., Ogawa M., and Yamaguchi Y. Blood concentrations of polymorphonuclear leukocyte elastase and interleukin-6 are indicators for the occurrence of multiple organ failures at the early stage of acute pancreatitis. J Gastroenterol Hepatol 13 (1998) 1274-1283
5. de Beaux A.C., Goldie A.S., Ross J.A., Carter D.C., and Fearon K.C. Serum concentrations of inflammatory mediators related to organ failure in patients with acute pancreatitis. Br J Surg 83 (1996) 349-353
6. Rau B., Steinbach G., Baumgart K., Gansauge F., Grunert A., and Beger H.G. Serum amyloid A versus C-reactive protein in acute pancreatitis. clinical value of an alternative acute-phase reactant. Crit Care Med 28 (2000) 736-742
7. Werdan K. The activated immune system in congestive heart failure-from dropsy to the cytokine paradigm. J Intern Med 243 (1998) 87-92
8. CASS Principal Investigators and Their Associates. Myocardial infarction and mortality in the Coronary Artery Surgery Study (CASS) randomized trial. N Engl J Med 310 (1984) 750-758
9. Clarke J.L., Anderson J.L., Carlquist J.F., Roberts R.F., Horne B.D., Bair T.L., Kolek M.J., Mower C.P., Crane A.M., Roberts W.L., Muhlestein J.B., and Intermountain Heart Collaborative Study Group. Comparison of differing C-reactive protein assay methods and their impact on cardiovascular risk assessment. Am J Cardiol 95 (2005) 155-158
10. Long-Term Intervention With Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
11. Gui D., Spada P.L., De Gaetano A., and Pacelli F. Hypocholesterolemia and risk of death in the critically ill surgical patient. Intensive Care Med 22 (1996) 790-794
12. Rauchhaus M., Clark A.L., Doehner W., Davos C., Bolger A., Sharma R., Coats A.J., and Anker S.D. The relationship between cholesterol and survival in patients with chronic heart failure. J Am Coll Cardiol 42 (2003) 1933-1940
13. Curb J.D., Abbott R.D., Rodriguez B.L., Masaki K., Popper J., Chen R., Petrovitch H., Blanchette P., Schatz I., and Yano K. Prospective association between low and high total and low-density lipoprotein cholesterol and coronary heart disease in elderly men. J Am Geriatr Soc 52 (2004) 1975-1980
14. Horwich T.B., Hamilton M.A., Maclellan W.R., and Fonarow G.C. Low serum total cholesterol is associated with marked increase in mortality in advanced heart failure. J Card Fail 8 (2002) 216-224
15. Lefer D.J. Statins as potent anti-inflammatory drugs. Circulation 106 (2002) 2041-2042
16. von Haehling S., Anker S.D., and Bassenge E. Statins and the role of nitric oxide in chronic heart failure. Heart Fail Rev 8 (2003) 99-106
17. Hayashidani S., Tsutsui H., Shiomi T., Suematsu N., Kinugawa S., Ide T., Wen J., and Takeshita A. Fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, attenuates left ventricular remodeling and cardiac failure after experimental myocardial infarction. Circulation 105 (2002) 868-873
18. Pliquett R.U., Cornish K.G., Peuler J.D., and Zucker I.H. Simvastatin normalizes autonomic neural control in experimental heart failure. Circulation 107 (2003) 2493-2498
19. Witte K.K., Clark A.L., and Cleland J.G. Chronic heart failure and micronutrients. J Am Coll Cardiol 37 (2001) 1765-1774
20. Fraunberger P., Scaefer S., Werdan K., Walli A.K., and Seidel D. Reduction of circulating cholesterol and apolipoprotein levels during sepsis. Clin Chem Lab Med 37 (1999) 357-362
21. Elliot D.C., and Wiles III C.E. Low lipid concentration in critical illness; hypocholesterolemia among trauma patients. Crit Care Med 22 (1994) 1437-1439
22. Fraunberger P., Nagel D., Walli A.K., and Seidel D. Serum cholesterol and mortality in patients with multiple organ failure. Crit Care Med 28 (2000) 3574-3575
23. Muhlestein J.B., Horne B.D., Bair T.L., Li Q., Madsen T.E., Pearson R.R., and Anderson J.L. Usefulness of in-hospital prescription of statin agents after angiographic diagnosis of coronary artery disease in improving continued compliance and reduced mortality. Am J Cardiol 87 (2001) 257-261